A wasted decade: Access to weight management interventions in England stagnateAccess to weight management (WM) interventions in England has not improved over the last ten years despite obesity rates continuing to...
How bariatric surgery reduces the risk of developing cardiovascular diseaseIn patients living with obesity, low-density lipoprotein (LDL) does not function normally increasing the risk of cardiovascular disease...
Researchers find target for prompting fat cells to expend energyResearchers at the University of Colorado School of Medicine have identified a potential target for treating obesity and metabolic...
How bariatric surgery reduces the risk of developing cardiovascular diseaseIn patients living with obesity, low-density lipoprotein (LDL) does not function normally increasing the risk of cardiovascular disease...
Structure announces positive results from oral GLP-1 receptor agonist gsbr-1290Structure Therapeutics has announced positive results from the Phase 1b multiple ascending dose (MAD) study of its highly selective oral...
Kallyope initiates study assessing new oral nutrient receptor agonists for the treatment of obesity Kallyope has initiated a Phase 2 trial evaluating K-757 and K-833, new oral nutrient receptor agonists being studied for obesity and Type...
A wasted decade: Access to weight management interventions in England stagnateAccess to weight management (WM) interventions in England has not improved over the last ten years despite obesity rates continuing to...
Genetics can predict and help improve outcomes after bariatric surgeryClinicians treating severe obesity have a new genetic tool for predicting and ultimately improving bariatric surgery outcomes, according...
NICE draft guidance approves of ESG as an option to treat obesityThe UK’s National Institute for Health and Care Excellence (NICE) has issued draft guidance stating that endoscopic sleeve gastroplasty...
European Medicines Agency to discuss anaesthesia risk for weight-loss drugsThe European Medicines Agency (EMA) will assess the risk that patients on weight loss drugs such as semaglutide and tirzepatide may...
Soleno reveals positive results from DCCR for Prader-Willi SyndromeSoleno Therapeutics has announced positive top-line results from the randomised withdrawal period of Study C602, a long-term treatment...
Women with obesity have worse menopause symptoms and get less relief from hormone therapyObesity may worsen a woman’s menopause symptoms and limit the amount of relief she gets from hormone therapy (HT), according to the...
Tirzepatide more effective in blood sugar control and body weight loss than semaglutideA new meta-analysis combining 22 studies shows that tirzepatide is superior to semaglutide for both control of blood sugar and in terms...
Journal Watch 27/09/2023Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...